Alternative Health Powered by Trendolizer

FDA Adds Boxed Warning to Canagliflozin for Amputation Risk

Trending story found on www.medscape.com
FDA Adds Boxed Warning to Canagliflozin for Amputation Risk
On the basis of new information from two cardiovascular outcomes trials suggesting a doubled amputation risk, the FDA will now require a boxed warning on canagliflozin's label.
[Source: www.medscape.com] [ Comments ] [See why this is trending]

Trend graph:

Comments